Accuvein® Veinfinder for Wrinkles

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
WrinklesAccuvein® Veinfinder - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is to see if vein mapping before facial injection procedures impacts patient outcomes and satisfaction.

Treatment Effectiveness

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: Approximately 7-10 days following the procedure

Day 10
Patient satisfaction
Rate of Bruising/Hematoma

Trial Safety

Trial Design

2 Treatment Groups

Control Goup
1 of 2
Intervention Group
1 of 2

Active Control

Experimental Treatment

60 Total Participants · 2 Treatment Groups

Primary Treatment: Accuvein® Veinfinder · No Placebo Group · N/A

Intervention Group
Device
Experimental Group · 1 Intervention: Accuvein® Veinfinder · Intervention Types: Device
Control GoupNoIntervention Group · 1 Intervention: Control Goup · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: approximately 7-10 days following the procedure

Who is running the clinical trial?

Mayo ClinicLead Sponsor
2,919 Previous Clinical Trials
3,516,920 Total Patients Enrolled
William Casey III, MDPrincipal InvestigatorMayo Clinic

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Who else is applying?

What state do they live in?
California100.0%
How old are they?
18 - 65100.0%
What portion of applicants met pre-screening criteria?
Did not meet criteria100.0%